Annual Revenue
N/A
30 April 2024
Summary:
PharmaCyte Biotech annual revenue is not available.PMCB Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
N/A
31 July 2024
Summary:
PharmaCyte Biotech quarterly revenue is not available.PMCB Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
N/A
31 July 2024
Summary:
PharmaCyte Biotech TTM revenue is not available.PMCB TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMCB Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
PMCB Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time |
PharmaCyte Biotech Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2013 | $12.20 K(-81.7%) | - | - |
| Oct 2012 | - | $6300.00(-4.5%) | $39.90 K(-25.3%) |
| July 2012 | - | $6600.00(-1.5%) | $53.40 K(-19.8%) |
| Apr 2012 | $66.60 K(-47.1%) | $6700.00(-67.0%) | $66.60 K(-40.0%) |
| Jan 2012 | - | $20.30 K(+2.5%) | $111.00 K(-9.5%) |
| Oct 2011 | - | $19.80 K(0.0%) | $122.70 K(+3.3%) |
| July 2011 | - | $19.80 K(-61.3%) | $118.80 K(-5.7%) |
| Apr 2011 | $126.00 K(-52.1%) | $51.10 K(+59.7%) | $126.00 K(+1.1%) |
| Jan 2011 | - | $32.00 K(+101.3%) | $124.60 K(-25.7%) |
| Oct 2010 | - | $15.90 K(-41.1%) | $167.70 K(-24.5%) |
| July 2010 | - | $27.00 K(-45.7%) | $222.00 K(-15.6%) |
| Apr 2010 | $262.90 K(-59.7%) | $49.70 K(-33.8%) | $262.90 K(-8.2%) |
| Jan 2010 | - | $75.10 K(+7.0%) | $286.30 K(-16.2%) |
| Oct 2009 | - | $70.20 K(+3.4%) | $341.60 K(-27.2%) |
| July 2009 | - | $67.90 K(-7.1%) | $469.20 K(-32.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2009 | $653.10 K(-45.1%) | $73.10 K(-43.9%) | $691.60 K(-18.6%) |
| Jan 2009 | - | $130.40 K(-34.1%) | $849.90 K(-17.4%) |
| Oct 2008 | - | $197.80 K(-31.9%) | $1.03 M(-11.2%) |
| July 2008 | - | $290.30 K(+25.5%) | $1.16 M(-2.6%) |
| Apr 2008 | $1.19 M(+1.7%) | $231.40 K(-25.2%) | $1.19 M(-11.6%) |
| Jan 2008 | - | $309.20 K(-5.7%) | $1.35 M(+20.2%) |
| Oct 2007 | - | $327.90 K(+2.0%) | $1.12 M(+13.1%) |
| July 2007 | - | $321.50 K(-17.1%) | $990.20 K(-15.3%) |
| Apr 2007 | $1.17 M(+117.8%) | $388.00 K(+368.0%) | $1.17 M(-2.7%) |
| Jan 2007 | - | $82.90 K(-58.1%) | $1.20 M(-2.7%) |
| Oct 2006 | - | $197.80 K(-60.5%) | $1.24 M(+19.1%) |
| July 2006 | - | $501.00 K(+19.0%) | $1.04 M(+93.3%) |
| Apr 2006 | $537.00 K(>+9900.0%) | $421.00 K(+262.9%) | $537.00 K(+362.9%) |
| Jan 2006 | - | $116.00 K(+559.1%) | $116.00 K(+559.1%) |
| July 2004 | - | $17.60 K | $17.60 K |
| Apr 2004 | $2400.00 | - | - |
FAQ
- What is the all time high annual revenue for PharmaCyte Biotech?
- What is the all time high quarterly revenue for PharmaCyte Biotech?
- What is the all time high TTM revenue for PharmaCyte Biotech?
What is the all time high annual revenue for PharmaCyte Biotech?
PharmaCyte Biotech all-time high annual revenue is $1.19 M
What is the all time high quarterly revenue for PharmaCyte Biotech?
PharmaCyte Biotech all-time high quarterly revenue is $501.00 K
What is the all time high TTM revenue for PharmaCyte Biotech?
PharmaCyte Biotech all-time high TTM revenue is $1.35 M